I have recently read an article called South African study highlights importance of research involving children the talks about a clinical trial entailing a group infants that have been diagnosed with HIV. After receiving informed consent form their mothers the infants were place on a drug called early antiretroviral (ARV).
The article explains, “Initial results from the Children with HIV Early Antiretroviral Therapy (CHER) study found a significant increase in survival among infants who received immediate ARV treatment. The trial started in July 2005 and is designed to continue through 201” (Keeton 2011). Furthermore, after a “routine review by the trial’s data and safety monitoring board in June this year, found that of the 377 babies enrolled, 96% were alive in the early treatment group compared to 84% in the delayed treatment group. The results were so striking that the board recommended that no additional infants be placed in the delayed treatment group and all babies be evaluated for initiation of ARV treatment” (Keeton 2011).
The mother of this child, Zama, said: “I did it for the sake of my child after she tested [HIV] positive. I gave informed consent when she was six weeks old. She has had no complications on treatment and is doing fine.” (Keeton 2011).
Finally, “The World Health Organization (WHO) recently finalized the first list of essential medicines for children, which will be released in November. Dr Sue Hill, WHO’s technical expert on the list, said the limited availability of appropriate children’s medicines contributes to childhood mortality” (Keeton 2011).
This article is an example of a positive example of the effects of research on children and/or families. The benefits outweighed the risks to the child.
Keeton, Claire ()2011). World Health Organization. South African study highlights importance of research involving children. Bull World Health Organ. 2007 October; 85(10): 738–740. doi: 10.2471/BLT.07.021007 Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636499/